Equitable Trust’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.51M | Sell |
35,909
-19,490
| -35% | -$1.36M | 0.13% | 138 |
|
|
2025
Q1 | $4.07M | Sell |
55,399
-645
| -1% | -$47.4K | 0.23% | 88 |
|
|
2024
Q4 | $3.67M | Sell |
56,044
-942
| -2% | -$61.7K | 0.2% | 99 |
|
|
2024
Q3 | $4.44M | Sell |
56,986
-950
| -2% | -$74K | 0.28% | 75 |
|
|
2024
Q2 | $4.52M | Buy |
57,936
+13,640
| +31% | +$1.06M | 0.31% | 74 |
|
|
2024
Q1 | $3M | Buy |
44,296
+348
| +0.8% | +$23.6K | 0.21% | 98 |
|
|
2023
Q4 | $2.96M | Sell |
43,948
-2,713
| -6% | -$183K | 0.22% | 89 |
|
|
2023
Q3 | $3.16M | Sell |
46,661
-949
| -2% | -$64.3K | 0.26% | 74 |
|
|
2023
Q2 | $3.41M | Sell |
47,610
-484
| -1% | -$34.6K | 0.26% | 70 |
|
|
2023
Q1 | $3.34M | Sell |
48,094
-6,230
| -11% | -$432K | 0.26% | 72 |
|
|
2022
Q4 | $3.68M | Sell |
54,324
-8,521
| -14% | -$578K | 0.29% | 72 |
|
|
2022
Q3 | $3.45M | Buy |
62,845
+58,546
| +1,362% | +$3.21M | 0.29% | 76 |
|
|
2022
Q2 | $284K | Hold |
4,299
| – | – | 0.02% | 329 |
|
|
2022
Q1 | $285K | Hold |
4,299
| – | – | 0.02% | 332 |
|
|
2021
Q4 | $250K | Hold |
4,299
| – | – | 0.02% | 339 |
|
|
2021
Q3 | $258K | Hold |
4,299
| – | – | 0.02% | 324 |
|
|
2021
Q2 | $258K | Sell |
4,299
-1
| -0% | -$60 | 0.02% | 325 |
|
|
2021
Q1 | $214K | Buy |
+4,300
| New | +$214K | 0.02% | 336 |
|